According to a report by Gatsby Foundation, they estimated that the U.K. will require 700,000 trained professionals by 2030 to support diagnostics in healthcare and its economy. Job satisfaction is one of the major associated issues, as there is no recognition of the individual and high work load due to the increased number of patients. This leads to exhaustion and also increases the chances of error in the results.
Access full Report @ https://www.databridgemarketresearch.com/reports/global-infection-control-market
Data Bridge Market Research analyses that the Infection Control Market was valued at USD 44.7 billion in 2021 and is further estimated to reach USD 65.04 billion by 2029 and is expected to grow at a CAGR of 4.8% during the forecast period of 2022 to 2029. Increase in prevalence of hospital-acquired infection, increasing geriatric population, growing demand of surgical procedures, and strategic initiatives by the government are the major drivers which propelled the demand for the infection control market in the forecast period.
The increasing prevalence of hospital-acquired infection across the world will drive the market's growth rate
All most every patient in the hospital or clinic is on the verge of getting Nosocomial infections. Moreover, the geriatric population is at a higher risk as compared to the younger population. The failure of the hospitals to follow the protocols regarding the safety of the patients includes failure of the healthcare workers in washing the hands along with the long hospital stays. Most of the patients who obtain infections from surgery spend almost 7 days in a hospital and also increase the chances of readmission of the patient after discharge. In addition, surgical infections account for about USD 10 billion annually in healthcare expenses. Thus, the increasing prevalence of hospital-acquired infection is driving the growth of infection control market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-microbial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
3M (U.S.), STERIS. (U.S.), Getinge AB (Sweden), Cantel Medical (U.S.), MATACHANA GROUP (Spain), Ecolab (U.S.), BELIMED, INC (Switzerland), Cardinal Health. (U.S.), Steelco S.p.A. (Italy), Reckitt Benckiser Group plc (U.K.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Covalon Technologies Ltd. (Canada), SKYTRON, LLC (U.S.), Olympus Corporation (Japan), COLTENE Group (Switzerland), Pal International (India), MELAG Medizintechnik GmbH & Co. K.G. (Germany), Cisa Production S.r.l. Unipersonale (Italy), Terragene (U.K.), The Clorox Company (U.S.) among others.
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global infection control market is categorized into four notable segments which are based on the basis of product, application, distribution channel and end user.
- On the basis of product, the market is segmented into sterilization products, cleaning and disinfection products, personal protective barriers, endoscope reprocessing products, anti-microbial surfaces and other infection control products. In 2022, sterilization products segment is expected to dominate the global infection control market with 46.42% market share due to the growing need to reduce surgical site infections (ISO), strict sterilization rules, and the extensive use of sterilizers in various applications such as sterilization of medical devices, sterilization of food and beverages, pharmaceutical sterilization and sterilization in the life sciences industry.
- On the basis of application, the market is segmented into surgical instruments, endoscopes, ultrasound probes and others. In 2022, surgical instruments segment is expected to dominate the global infection control market with 55.09% market share. The increasing prevalence and burden of HAIs and chronic diseases, the growing geriatric population and the increasing number of surgeries are the main factors driving the use of surgical instruments, which has spurred the demand for effective cleaning and disinfection.
- On the basis of distribution channel, the market is segmented into direct tender, third party distributors and retail sales. In 2022, direct tender segment is expected to dominate the global infection control market with 46.42% market share because direct tenders have the largest market share as most of the service providers purchase the devices from the manufacturers, and noticed that direct sales revenues are higher which is influential and growing in the infection control market.
The direct tender segment will dominate the distribution channel segment of the infection control market
The hospital pharmacy segment will emerge as the dominating segment under distribution channel with approximately 46.00% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
- On the basis of end user, the market is segmented into hospitals, clinics, medical device companies, pharmaceutical and biotechnology companies, laboratories and others. In 2022, hospitals segment is expected to dominate the global infection control market with 63.69% market share mainly due to the increase in the prevalence of HAI and the increase in the geriatric population as this segment of the population is more susceptible to various chronic diseases. The increasing number of surgeries is also contributing significantly to the growth of the infection control market for hospitals segment.
The hospitals segment will dominate the end user segment of the infection control market
The hospitals segment will emerge as the dominating segment end user segment. This is because of the growing number of hospitals in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in infection control market: 3M (U.S.), STERIS. (U.S.), Getinge AB (Sweden), Cantel Medical (U.S.), MATACHANA GROUP (Spain), Ecolab (U.S.), BELIMED, INC (Switzerland), Cardinal Health. (U.S.), Steelco S.p.A. (Italy), Reckitt Benckiser Group plc (U.K.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Covalon Technologies Ltd. (Canada), SKYTRON, LLC (U.S.), Olympus Corporation (Japan), COLTENE Group (Switzerland), Pal International (India), MELAG Medizintechnik GmbH & Co. K.G. (Germany), Cisa Production S.r.l. Unipersonale (Italy), Terragene (U.K.), The Clorox Company (U.S.).
Market Development
- In May 2020, Getinge AB launched superfast indicators to ensure patient safety further. The new Superfast 20 indicators are compatible with most of the brands of steam and hydrogen peroxide process sterilizers and comply with ISO 11138. This product launch will help the company to grow its share in global patient safety market
- In April 2019, Cardinal Health announced the acquisition of MSCRIPTS, a company that delivers patient adherence and engagement solutions through an innovative, easy-to-use mobile and web-based health management platform. This will help the company to support patient adherence to prescriptions and improve overall health results
Regional Analysis
Geographically, the countries covered in the infection control market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in infection control market during the forecast period 2022 to 2029
North America dominates the infection control market due to the increased efforts of established companies. Furthermore, the steady number of strategic associations adopted by key market players will further boost the region's infection control market growth during the forecast period.
Asia-Pacific is estimated to be the fastest growing region in infection control market the forecast period 2022 to 2029
Asia-Pacific is projected to observe a significant amount of growth during the forecast period in the infection control market due to the rise in the occurrence of outsourcing organizations. Moreover, the increasing healthcare expenses is further anticipated to propel the growth of the infection control market in the region in the coming years.
COVID-19 Impact
The COVID-19 pandemic has severely impacted the market for infection management. Worldwide healthcare systems have been devastated by the pandemic, with hospitals becoming overcrowded as patient numbers rise. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because to the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely in the post-COVID situation.
For more detailed information about the infection control on market report, click here – https://www.databridgemarketresearch.com/reports/global-infection-control-market
